Sunday, 8 November 2026
Independent coverage of global markets, trade and finance
(RTTNews) - Wednesday. Eli Lilly and Company (LLY) reported detailed results from the Phase 3 ACHIEVE-4 trial showing that Foundayo (orforglipron) demonstrated cardiovascular safety alongside sustained A1C reduction and…
November WTI crude oil (CLX26) closed up +1.04 (+1.16%) on Wednesday, and November RBOB gasoline (RBX26) closed up +0.1282 (+4.09%).
Nat-gas prices recovered from early losses on Wednesday and settled higher on expectations for a smaller-than-average build in weekly gas storage. The consensus is that Thursday’s weekly EIA nat-gas inventories rose +63…
The dollar index (DXY00 ) is down by -0.17% today. US economic news today showing weaker-than-expected inflation readings on Aug core PCE price index and the Q2 core PCE price index eases the chance of a Fed rate hike n…
Vanguard High Dividend Yield ETF has a significantly lower expense ratio and higher assets under management (AUM) than Fidelity High Dividend ETF.
(RTTNews) - Eli Lilly and Company (LLY) said on Wednesday that its investigational EloraTZP combination of eloralintide and tirzepatide delivered substantial weight loss and reductions in blood sugar levels in a Phase 2…
Fintel reports that on September 30, 2026, Stifel initiated coverage of Achieve Life Sciences (NASDAQCM:ACHV) (DB:SP4P) with a Buy recommendation.
The S&P 500 index currently trades at 26.3 times earnings. That's well above its long-term average of roughly 16 times earnings.
Semiconductor manufacturers are racing to expand their production capacity to meet demand from artificial intelligence (AI) customers.
Target began paying quarterly dividends when it went public 59 years ago. There have been eight U.S. recessions in that time.
It launched a second $1 billion ATM stock sale after it exhausted that offering.
The S&P 500 Index ($SPX) (SPY) is up by +0.34% today, the Dow Jones Industrial Average ($DOWI) (DIA) is up by +0.07%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.52%. December E-mini S&P futures (ESZ26) are up +0.35…
(RTTNews) - U.K. stocks gained some ground in positive territory on Wednesday thanks to stronger-than-expected GDP data. However, the mood remained cautious due the rebound by oil prices amid supply concerns due to cont…
Shares of Nebius have soared in 2026, and further upside cannot be ruled out given its robust backlog.
(RTTNews) - The following biotech stocks reached a 52-week high on September 29, 2026, driven by key catalysts such as promising results from clinical trials or revised financial guidance.
Dogecoin was created as a joke by two friends who felt the cryptocurrency industry was taking itself too seriously.
The S&P 500 Index ($SPX) (SPY) closed down by -0.17% on Tuesday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down by -0.26%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.21%. December E-mini S&P futures…
(RTTNews) - The French stock market's benchmark index CAC 40 slipped into negative territory on Wednesday, failing to hold early gains, as oil prices climbed higher on supply concerns amid lingering uncertainty about Ir…
The transaction involved 3,300 shares executed at a weighted average price of $296.58, totaling ~$979,000.
Despite not capturing the same level of market attention as some of its mega-cap technology sector peers, Oracle (NYSE: ORCL) has quietly emerged as a major winner in the artificial intelligence (AI) revolution. A surge…
(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) announced positive topline results from its pivotal Phase 3 study of HETLIOZ (tasimelteon) in adults with Delayed Sleep-Wake Phase Disorder, a circadian rhythm disorder that…
October NY world sugar #11 (SBV26) closed up +0.36 (+2.06%) on Tuesday, and December London ICE white sugar #5 (SWZ26) closed up +5.40 (+1.07%).
(RTTNews) - Larimar Therapeutics, Inc. (LRMR), a clinical-stage biotechnology company, announced the appointment of John Harlow as President and Chief Operating Officer, effective September 29, 2026. He will report to C…
(RTTNews) - Eli Lilly and Company (LLY) announced detailed results from the Phase 3 TRIUMPH-2 study showing that retatrutide delivered substantial weight loss and blood sugar improvements in adults living with obesity o…